---
figid: PMC9243315__gr2
figtitle: 'Paradoxical roles of miR-4295 in human cancer: Implications in pathogenesis
  and personalized medicine'
organisms:
- NA
pmcid: PMC9243315
filename: gr2.jpg
figlink: /pmc/articles/PMC9243315/figure/fig2/
number: F2
caption: miR-4295 plays a role in multiple cancers through different pathways. miR-4295
  inhibits the expression of TP63 and BTG1 in bladder cancer, and inhibites the expression
  of USP28 to exert a tumor suppressing effect. miR-4295 also promotes the expression
  of CDKN1A in prostate cancer. In gastric cancer, miR-4295 down-regulates the expression
  of BAX and Caspase-3 and inhibits EREG/PI3K/Akt signaling pathway by targeted down-regulation
  of LRIG1. miR-4295 inhibits GPC5 expression and promotes Wnt/β-catenin signaling
  pathway in pancreatic ductal adenocarcinoma. In IH, miR-4295 up-regulates the expression
  of VEGF-A, VEGF, FLT1, FOXF1 and FLT2. In gliomas, miR-4295 reduces the expression
  of RUNX3. In HNSCC, miR-4295 reduced the expression of NPTX1. In osteosarcoma, up-regulation
  of miR-4295 reduce the expression of PTPN14 to promote oncogenesis. In non-small
  cell lung cancer, low expression of miR-4295 reduces the expression of SOS2 and
  EREG, whereas miR-4295 inhibits the expression of USP28 in non-small cell lung cancer,
  and acting as a tumor suppressor.
papertitle: 'The paradoxical roles of miR-4295 in human cancer: Implications in pathogenesis
  and personalized medicine.'
reftext: Yin Li, et al. Genes Dis. 2022 May;9(3):638-647.
year: '2022'
doi: 10.1016/j.gendis.2020.09.007
journal_title: Genes & Diseases
journal_nlm_ta: Genes Dis
publisher_name: Chongqing Medical University
keywords: Cancer | Cancer cells | miR-4295 | Molecular function | Prognosis | Tumor
  suppressor
automl_pathway: 0.7625518
figid_alias: PMC9243315__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9243315__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9243315__gr2.html
  '@type': Dataset
  description: miR-4295 plays a role in multiple cancers through different pathways.
    miR-4295 inhibits the expression of TP63 and BTG1 in bladder cancer, and inhibites
    the expression of USP28 to exert a tumor suppressing effect. miR-4295 also promotes
    the expression of CDKN1A in prostate cancer. In gastric cancer, miR-4295 down-regulates
    the expression of BAX and Caspase-3 and inhibits EREG/PI3K/Akt signaling pathway
    by targeted down-regulation of LRIG1. miR-4295 inhibits GPC5 expression and promotes
    Wnt/β-catenin signaling pathway in pancreatic ductal adenocarcinoma. In IH, miR-4295
    up-regulates the expression of VEGF-A, VEGF, FLT1, FOXF1 and FLT2. In gliomas,
    miR-4295 reduces the expression of RUNX3. In HNSCC, miR-4295 reduced the expression
    of NPTX1. In osteosarcoma, up-regulation of miR-4295 reduce the expression of
    PTPN14 to promote oncogenesis. In non-small cell lung cancer, low expression of
    miR-4295 reduces the expression of SOS2 and EREG, whereas miR-4295 inhibits the
    expression of USP28 in non-small cell lung cancer, and acting as a tumor suppressor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB2
  - USP28
  - SOS2
  - EREG
  - PTPN14
  - VEGFA
  - NPTX1
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - IH
  - RUNX3
  - MIR4295
  - TP63
  - PC
  - FGFR1
  - GC
  - BTG1
  - PPBP
  - BAX
  - GPC5
  - AKT1
  - AKT2
  - AKT3
  - EGFR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
---
